Loading the company…
Loading the company…
No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In the last ten years FDA made 23 decisions for Conformis (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families, the most in 2023 (6). The latest was on 2023-09-08.
| Date | Kind | Number | Device |
|---|---|---|---|
| 2023-09-08 | 510(k) | K232426 | Identity Imprint Porous Cruciate Retaining (CR) Knee Replacement System (KRS) with Cruciate Sacrificing (CS) Inserts |
| 2023-07-21 | 510(k) | K223316 | Identity Imprint Porous Total Knee Replacement System, Identity Imprint Porous Cruciate Retaining Total Knee Replacement System |
| 2023-07-17 | 510(k) | K230846 | iTotal Identity Knee Replacement System; Identity Imprint Knee Replacement System |
| 2023-05-26 | 510(k) | K231233 |
| Identity Imprint CR KRS and Identity Imprint PS KRS |
| 2023-05-23 | 510(k) | K231178 | ACTERA hip system |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Conformis.